Breast cancer can sometimes spread beyond the breast and nearby lymph nodes to other parts of the body. This is known as metastatic breast cancer, also called stage IV or advanced breast cancer. It can affect areas such as the bones, lungs, liver and brain, and may develop when breast cancer returns after earlier treatment or when it has already spread at the time of initial diagnosis.
A diagnosis of metastatic breast cancer can be difficult for patients and their families. However, treatment options are available, and advances in medical oncology have expanded the ways doctors can manage the disease. Treatment may help control cancer growth, relieve symptoms, preserve quality of life and, in some cases, help patients live for many years.
Understanding the symptoms, diagnostic process and available treatment approaches can help patients make informed decisions with their oncology team.
What Is Metastatic Breast Cancer?
Metastatic breast cancer occurs when cancer cells break away from the original breast tumour and travel through the bloodstream or lymphatic system to establish tumours in other parts of the body. Even when breast cancer spreads to another organ, it remains breast cancer. For example, if breast cancer cells form a tumour in the liver, the condition is described as breast cancer that has spread to the liver, rather than primary liver cancer.
The most common sites of breast cancer metastasis include:
- Bones: Breast cancer can spread to the spine, ribs, pelvis and other bones.
- Lungs: Cancer cells may form secondary tumours in one or both lungs.
- Liver: The disease can affect liver tissue and its normal function.
- Brain: Cancer cells may spread to the brain and surrounding structures.
Metastatic disease can develop at different points in a person’s cancer journey. Some patients are diagnosed with stage IV disease from the beginning. Others develop distant recurrence months or even years after completing treatment for an earlier stage of breast cancer.
Importantly, metastatic breast cancer is different from locally advanced breast cancer. Locally advanced disease may involve nearby tissues or lymph nodes, whereas metastatic disease has spread to distant organs or tissues.
Symptoms of Metastatic Breast Cancer
The symptoms of metastatic breast cancer depend largely on where the cancer has spread. Some patients experience noticeable symptoms, while others may have few or no symptoms, particularly during the early stages of metastatic disease. The following signs may require medical assessment, especially in someone with a previous breast cancer diagnosis.
1. Bone Pain and Fractures
When breast cancer spreads to the bones, patients may experience persistent pain in the back, hips, ribs or other affected areas. The pain may become more noticeable at night or during movement. Cancer affecting the bones can also weaken them, increasing the risk of fractures. In some cases, spinal involvement may cause pressure on the spinal cord, which requires urgent medical attention.
2. Persistent Cough or Shortness of Breath
If cancer spreads to the lungs, symptoms may include:
- Persistent or unexplained cough
- Shortness of breath
- Chest discomfort
- Difficulty breathing during physical activity
These symptoms can also result from respiratory infections and other conditions. Medical evaluation is important to identify their underlying cause.
3. Abdominal Discomfort and Liver-Related Symptoms
Metastatic breast cancer involving the liver may cause discomfort or pain in the upper right side of the abdomen. Some patients may experience abdominal swelling, reduced appetite, nausea or unexplained weight changes. In more advanced cases, jaundice may develop. This causes yellowing of the skin and the whites of the eyes and can indicate impaired liver function.
4. Headaches and Neurological Changes
When breast cancer spreads to the brain, symptoms may include:
- Persistent or worsening headaches
- Dizziness or balance difficulties
- Seizures
- Changes in vision
- Speech difficulties
- Weakness or numbness in certain parts of the body
New seizures, sudden weakness, significant changes in vision or speech, and severe or rapidly worsening headaches need prompt medical assessment.
5. General Symptoms
Some symptoms are not specific to one metastatic site. They may include persistent fatigue, unexplained weight loss, reduced appetite and a general decline in physical well-being. These symptoms do not necessarily indicate metastatic cancer. However, patients with a history of breast cancer should discuss persistent or unusual changes with their healthcare provider rather than assuming they are related to previous treatment.
How Is Metastatic Breast Cancer Diagnosed?
Diagnosing metastatic breast cancer involves confirming whether the disease has spread, identifying the affected areas and understanding the biological characteristics of the tumour. An oncologist may recommend several investigations depending on the patient’s symptoms, medical history and previous treatment.
Medical History and Physical Examination
The diagnostic process generally begins with a review of the patient’s previous breast cancer diagnosis, treatments, current symptoms and overall health. The oncologist may perform a physical examination and assess any areas of concern. Previous imaging reports, biopsy findings and treatment records can also provide important information.
Imaging Tests
Imaging investigations help doctors identify possible areas of cancer spread and assess the extent of the disease. Depending on the clinical situation, these may include:
- CT scan: Provides detailed images of internal organs and tissues, including the chest, abdomen and pelvis.
- MRI: May be used to examine the brain, spine or other areas requiring more detailed imaging.
- PET-CT scan: Helps identify areas of increased metabolic activity that may indicate cancer involvement.
- Bone scan: May be recommended when bone metastasis is suspected.
The choice of imaging depends on the patient’s symptoms and the information needed to guide treatment.
Biopsy and Biomarker Testing
A biopsy may be performed on a suspected metastatic site when it is safe and clinically appropriate. Examining a tissue sample can help confirm whether the lesion represents metastatic breast cancer. Doctors may also repeat biomarker testing to assess:
- Oestrogen receptor (ER) status
- Progesterone receptor (PR) status
- HER2 status
These markers are important because they influence which treatments may be effective. The receptor status of a metastatic tumour can sometimes differ from that of the original breast cancer. Additional molecular or genetic tests may be considered when appropriate. These can help identify specific changes that may make certain targeted treatments suitable.
Blood Tests
Blood tests may help assess general health and organ function, including liver and kidney function. They may also provide information about blood cell counts and other factors relevant to treatment planning. No single blood test can independently confirm or rule out metastatic breast cancer. Results must be interpreted alongside imaging, clinical findings and, where appropriate, biopsy results.
Understanding the Stages of Breast Cancer
Breast cancer is generally classified into stages 0 through IV. Staging helps doctors understand how far the cancer has developed and supports treatment planning.
- Stage 0: Abnormal cells are confined to the milk ducts or lobules and have not invaded surrounding breast tissue.
- Stage I: The cancer is invasive but relatively small and may involve only limited nearby lymph node tissue.
- Stage II: The tumour may be larger or may have spread to nearby lymph nodes.
- Stage III: The cancer may involve more extensive nearby lymph nodes or surrounding tissues, including the skin or chest wall.
- Stage IV: Cancer has spread beyond the breast and nearby lymph nodes to distant parts of the body.
Stage IV breast cancer is also known as metastatic breast cancer. At this stage, treatment planning focuses on managing the disease throughout the body rather than treating only the original breast tumour.
Metastatic Breast Cancer Treatment Approaches
The treatment of metastatic breast cancer is individualised. There is no single treatment plan suitable for every patient. Doctors consider the tumour’s hormone receptor and HER2 status, molecular test results, previous treatments, sites of spread, symptoms and the patient’s general health. The main objectives are to control cancer growth, reduce symptoms, maintain quality of life and extend survival where possible.
1. Hormone Therapy
Hormone therapy may be recommended for hormone receptor-positive breast cancer, which means the cancer cells have receptors for oestrogen and/or progesterone. These treatments work by reducing the effect of hormones on cancer cells or limiting the body’s production of certain hormones. Examples include aromatase inhibitors, tamoxifen and other endocrine therapies. Hormone therapy is often combined with targeted medicines, such as CDK4/6 inhibitors, depending on the patient’s tumour characteristics and previous treatment.
2. HER2-Targeted Therapy
Some breast cancers produce higher-than-normal levels of a protein called HER2, which can encourage cancer cell growth. HER2-targeted medicines are designed to interfere with this protein or the pathways involved in cancer cell growth. They may be used alone or in combination with chemotherapy or other medicines, depending on the treatment setting. These therapies have significantly expanded treatment options for patients with HER2-positive metastatic breast cancer.
3. Chemotherapy
Chemotherapy uses medicines that damage or destroy rapidly dividing cancer cells. It may be recommended when breast cancer is hormone receptor-negative, when the disease is progressing quickly, or when other treatments are no longer effective. The specific medicines, combinations and treatment schedule depend on the cancer subtype, previous therapies, expected benefits and possible side effects. Chemotherapy may be given in cycles, allowing time for the body to recover between treatments.
4. Immunotherapy
Immunotherapy helps the immune system recognise and attack cancer cells. Its use in metastatic breast cancer depends on the tumour subtype and specific biomarkers.
For selected patients with advanced triple-negative breast cancer, immunotherapy may be combined with chemotherapy. Tests such as PD-L1 assessment can help determine whether certain immunotherapy approaches may be appropriate. Immunotherapy is not suitable for every patient, and its potential benefits and risks need to be assessed individually.
5. Other Targeted Treatments
Targeted therapies focus on specific proteins, genes or molecular pathways involved in cancer growth. Depending on the patient’s tumour characteristics, treatment may include medicines directed at particular genetic changes or other biological features.
For example, PARP inhibitors may be considered for certain patients with HER2-negative breast cancer and inherited BRCA1 or BRCA2 gene mutations. Other targeted medicines may be appropriate for patients whose tumours have specific molecular alterations. Biomarker and genetic testing can therefore play an important role in treatment selection.
6. Radiation Therapy and Surgery
Although systemic medicines are generally the main treatment for metastatic breast cancer, local treatments may also have an important role. Radiation therapy may be used to relieve pain from bone metastases, manage symptoms caused by brain involvement or control a tumour affecting a particular area.
Surgery may be considered in selected circumstances, such as managing a painful breast tumour, treating certain complications or addressing structural problems caused by cancer spread. These treatments are usually considered as part of a broader care plan rather than as replacements for systemic treatment.
7. Supportive and Palliative Care
Supportive care is an important part of metastatic breast cancer management. It focuses on reducing the physical and emotional effects of cancer and its treatment. Depending on the patient’s needs, supportive care may include:
- Pain and symptom management
- Support for fatigue, nausea and appetite changes
- Nutritional guidance
- Emotional and psychological support
- Management of treatment-related side effects
- Assistance with daily activities and overall well-being
Palliative care can be provided alongside active cancer treatment. It is not limited to end-of-life care and can help patients manage symptoms and maintain quality of life throughout their treatment journey.
How Do Oncologists Choose the Right Treatment?
Treatment decisions for metastatic breast cancer require careful evaluation. Two patients with the same stage of cancer may receive different treatment plans because their tumours, medical histories and treatment needs may not be the same. An oncologist may consider several factors:
Tumour biology: ER, PR and HER2 status, along with relevant molecular or genetic findings, can influence treatment selection.
Previous treatment: Medicines or therapies used during earlier treatment may affect which options are appropriate next.
Location of metastases: Cancer involving the bones, liver, lungs or brain may require different combinations of systemic and local treatment.
Overall health: Age, organ function, other medical conditions and the patient’s ability to tolerate treatment are important considerations.
Treatment goals and preferences: Patients should have an opportunity to discuss the potential benefits, side effects and practical considerations of each option.
Treatment may be adjusted over time if the cancer progresses, becomes resistant to a medicine or causes new symptoms. Regular monitoring helps the oncology team assess whether the current approach remains appropriate.
Living With Metastatic Breast Cancer
Living with metastatic breast cancer involves more than managing the disease itself. Patients may face physical symptoms, treatment-related challenges, emotional stress and uncertainty about the future. Maintaining regular communication with the oncology team can help patients understand changes in their condition and address concerns early. A few practical considerations may support ongoing care:
- Attend scheduled appointments and recommended scans.
- Report new or worsening symptoms to the healthcare team.
- Discuss side effects rather than stopping prescribed treatment independently.
- Ask about supportive care for pain, fatigue, sleep and emotional well-being.
- Keep copies of pathology reports, imaging results and treatment records.
- Consider a second medical opinion if additional clarity about treatment options would be helpful.
It is also important for patients and families to understand that metastatic breast cancer can behave differently from one person to another. Treatment response and disease progression vary, so an individual’s outlook cannot be determined by stage alone.
Frequently Asked Questions
Is metastatic breast cancer the same as stage IV breast cancer?
Yes. Metastatic breast cancer is classified as stage IV breast cancer because it has spread beyond the breast and nearby lymph nodes to distant parts of the body, such as the bones, liver, lungs or brain.
Can metastatic breast cancer be treated?
Yes. Several treatment options are available, including hormone therapy, chemotherapy, targeted therapy and immunotherapy for selected patients. Radiation therapy and surgery may also help manage specific symptoms or complications.
What are the most common sites of breast cancer metastasis?
Breast cancer most commonly spreads to the bones, lungs, liver and brain. The location of metastasis influences the symptoms a patient may experience and the investigations or treatments recommended.
Can breast cancer spread after successful treatment?
Yes. Breast cancer can return after treatment and spread to distant organs. This is known as distant recurrence or metastatic recurrence. It may occur months or years after the original diagnosis, which is one reason ongoing follow-up care is important.
Does metastatic breast cancer always cause symptoms?
No. Some patients have no noticeable symptoms when metastatic disease is first identified. Others may experience symptoms related to the affected organ, such as bone pain, persistent cough, abdominal discomfort or neurological changes.
How is treatment monitored?
Doctors may monitor treatment response through physical examinations, imaging scans, blood tests and assessment of symptoms. The frequency and type of monitoring depend on the patient’s condition and treatment plan.
Is chemotherapy always necessary for metastatic breast cancer?
No. Chemotherapy is one of several treatment options. Some patients may benefit from hormone therapy, targeted therapy or other approaches depending on their tumour characteristics. The oncologist determines the most suitable treatment based on individual findings.
Conclusion
Metastatic breast cancer is a complex condition that requires an individualised and carefully monitored treatment approach. Although it represents an advanced stage of the disease, several treatment options are available to help control cancer growth, manage symptoms and support quality of life.
Accurate diagnosis, biomarker testing and regular assessment are important in selecting the most appropriate treatment. With guidance from an experienced medical oncology team, patients can better understand their options and make informed decisions at each stage of care.
Take the Next Step with an Expert Consultation
A metastatic breast cancer diagnosis can raise important questions about treatment choices, disease management and what to expect in the months ahead. A consultation with Dr. Pranay Girdhari Taori, Specialist Medical Oncologist, can help patients understand their diagnosis and discuss treatment options based on their medical history, tumour characteristics and individual needs.
With more than 27 years of dedicated experience in medical oncology, Dr. Taori focuses on personalised cancer care, evidence-based treatment planning and supporting patients throughout their treatment journey. Book a consultation to discuss your diagnosis and explore the available treatment approaches.
